课题基金 / 基金详情

Mdig gene and histone demethylation in lung cancer

Mdig gene and histone demethylation in lung cancer
肺癌中的 Mdig 基因和组蛋白去甲基化
批准号:
7577267
负责人:
Fei Chen
金额:
$29.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-02-28

项目摘要

项目成果

Fei Chen的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肺癌是全球最常见的癌症,每年有130万人死于癌症。尽管广泛的努力,阐明机制和开发新的治疗方案,全球肺癌的死亡率仍然很高。我们的长期目标是了解mdig基因在人类肺癌发生发展中的作用,以及mdig基因是否可以作为环境或职业危害所致肺癌的生物标志物和治疗靶点。本申请的目的是研究Mdig蛋白在环境和职业危害/致癌物诱导的肺细胞增殖和致癌转化中的作用。中心假设是Mdig通过作为组蛋白脱甲基酶拮抗组蛋白H3上的三甲基赖氨酸9来促进细胞生长和转化。下调组蛋白H3的三甲基赖氨酸9的表达,将增强与细胞周期调控和肺上皮细胞恶性转化相关基因的表达。这一建议背后的基本原理是mdig基因的表达可能是肺细胞增殖和致癌转化的关键,以应对环境致癌物。为了实现本申请的目的,我们将通过使用细胞系和裸鼠作为实验模型来追求三个具体目标:(1)测试mdig蛋白对组蛋白H3上的三甲基化赖氨酸9的潜在脱甲基酶活性;(2)确定细胞周期调节基因(例如细胞周期蛋白、Cdc 25和检查点蛋白)的表达是否受mdig的甲基化调节的调节;(3)通过细胞培养和裸鼠体内接种两种方法,研究mdig在BEAS-2B细胞和A549细胞中过表达和下调mdig的致瘤作用。在完成这些特定目标后,我们期望能够确定mdig如何促进肺细胞生长调节和致癌转化,以应对导致肺癌的因素。根据初步研究,我们还预计mdig的组成性表达将损害组蛋白H3上赖氨酸9的三甲基化,导致异染色质的减弱或其他抑制性表观遗传标记的形成。因此,与细胞周期转换和细胞增殖相关的基因的表达将增强。最后,除了揭示一个以前未知的人肺癌的新机制外,预期mdig的表达可潜在地作为人肺癌的新生物标志物和治疗靶点。公共卫生相关性:肺癌是美国(US)恶性肿瘤相关死亡的主要原因。它比任何其他类型的恶性肿瘤杀死更多的美国人。肺癌的主要原因是环境和职业暴露于致癌物,包括吸烟和职业粉尘。本项目将通过验证mdig基因通过下调组蛋白H3上赖氨酸9的三甲基化和异染色质的形成来诱导细胞生长和转化的假说,探讨mdig基因这一新发现的肺癌相关基因介导致癌物诱导肺癌的机制。本研究的长期目标是了解mdig基因在环境和职业危害诱发的肺癌发生和发展中的作用,寻找早期发现肺癌的生物标志物,并制定干预和预防策略。
英文摘要
DESCRIPTION (provided by applicant): Lung cancer is the most common cancer worldwide, accounting for 1.3 million cancer deaths annually. Despite extensive efforts to elucidate mechanisms and develop new therapeutic regimens, the worldwide mortality rate of lung cancer remains high. Our long- term goal is to understand how mdig gene contributes to the initiation and progression of the human lung cancer and whether mdig can be served as a biomarker and a therapeutic target for lung cancer resulted from exposure to environmental or occupational hazards. The objective of this application is to investigate the role of Mdig protein played on the lung cell proliferation and carcinogenic transformation induced by environmental and occupational hazards/carcinogens. The central hypothesis is that Mdig promotes cell growth and transformation by functioning as a histone demethylase that antagonizes tri-methyl lysine 9 on histone H3. Down-regulation of tri-methyl lysine 9 of histone H3 will enhance the expression of genes associated with the cell cycle regulation and malignant transformation in lung epithelial cells. The rationale behind this proposal is that expression of mdig gene may be critical for lung cell proliferation and carcinogenic transformation in response to environmental carcinogens. To accomplish the objectives of this application, we will pursue three specific aims by using cell lines and nude mice as experimental models: (1) test the potential demethylase activity of mdig protein toward tri-methylated lysine 9 on histone H3; (2) determine whether the expression of the cell cycle-regulated genes, such as cyclins, Cdc25s and checkpoint proteins, is regulated by the methylation regulation of mdig; and (3) study the tumorigenic effect of mdig by both over- expression and down-regulation of mdig in BEAS-2B cells and A549 cells, respectively, in both cell culture and inoculation of the cells in nude mice. At the completion of these specific aims, we expect to have determined how mdig contributes to lung cell growth regulation and carcinogenic transformation in response to factors that cause lung cancer. We additionally expect, based on preliminary studies, that constitutive expression of mdig will compromise the tri-methylation of lysine 9 on histone H3, leading to attenuation of heterochromatin or the formation of other inhibitory epigenetic markers. As a result, the expression of genes associated with the cell cycle transition and cell proliferation will be enhanced. Finally, in addition to reveal a previously unknown new mechanism of the human lung cancer, it is anticipated that expression of mdig can be potentially served as a new biomarker and therapeutic target of the human lung cancer. PUBLIC HEALTH RELEVANCE: Lung cancer is the leading cause of malignant-related deaths in the United States (US). It kills more Americans than any other type of malignancy. The main cause of lung cancer is the environmental and occupational exposure to carcinogens, including tobacco smoking and occupational dust. This project will investigate the mechanism of mdig gene, a newly identified lung cancer associated gene, in mediating carcinogen-induced lung cancer by testing the hypothesis that mdig inducing cell growth and transformation through down regulation of the tri-methylation of lysine 9 on histone H3 and the heterochromatin formation. The long-term goals are to understand how mdig gene contributes to the initiation and progression of the human lung cancer induced by environmental and occupational hazards, to identify biomarkers for early detection of the lung cancer and to develop intervention and prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
  • 批准号:
    10565141
  • 项目类别:
  • 资助金额:
    $69.13万
  • 财政年份:
    2023
  • 负责人:
    Fei Chen
  • 依托单位:
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
海外基金